Jo U - Search Results

1

Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms.

Kang J, Park JH, Lee HJ, Jo U, Park JK, Seo JH, Kim YH, Kim I, Park KH. Kang J, et al. Among authors: jo u. Cancer Res Treat. 2016 Apr;48(2):715-26. doi: 10.4143/crt.2015.227. Epub 2015 Sep 21. Cancer Res Treat. 2016. PMID: 26511813 Free PMC article.

2

Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.

Murai J, Ceribelli M, Fu H, Redon CE, Jo U, Murai Y, Aladjem MI, Thomas CJ, Pommier Y. Murai J, et al. Among authors: jo u. Mol Cancer Ther. 2023 Aug 1;22(8):985-995. doi: 10.1158/1535-7163.MCT-22-0552. Mol Cancer Ther. 2023. PMID: 37216280 Free PMC article.

3

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.

Jo UH, Han SG, Seo JH, Park KH, Lee JW, Lee HJ, Ryu JS, Kim YH. Jo UH, et al. BMC Cancer. 2008 Dec 4;8:359. doi: 10.1186/1471-2407-8-359. BMC Cancer. 2008. PMID: 19055823 Free PMC article.

4

Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.

Whang YM, Park KH, Jung HY, Jo UH, Kim YH. Whang YM, et al. Cancer. 2009 Mar 15;115(6):1253-66. doi: 10.1002/cncr.24113. Cancer. 2009. PMID: 19156899 Free article.

5

AKAP12alpha is associated with promoter methylation in lung cancer.

Jo U, Whang YM, Kim HK, Kim YH. Jo U, et al. Cancer Res Treat. 2006;38(3):144-51. doi: 10.4143/crt.2006.38.3.144. Epub 2006 Jun 30. Cancer Res Treat. 2006. PMID: 19771275 Free PMC article.

6

A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population.

Kim HK, Jung HY, Lim S, Sung JS, Whang YM, Jo U, Lee JE, Shin SW, Kim JS, Ryu JS, Kim YH. Kim HK, et al. Among authors: jo u. Anticancer Res. 2010 Sep;30(9):3621-7. Anticancer Res. 2010. PMID: 20944145

7

Methylation of AKAP12{alpha} promoter in lung cancer.

Jo UH, Whang YM, Sung JS, Kim YH. Jo UH, et al. Anticancer Res. 2010 Nov;30(11):4595-600. Anticancer Res. 2010. PMID: 21115911

8

Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?

Kim ST, Jung HY, Sung JS, Jo UH, Tanaka T, Hagiwara K, Park KH, Shin SW, Kim JS, Kim YH. Kim ST, et al. Am J Clin Oncol. 2013 Feb;36(1):57-63. doi: 10.1097/COC.0b013e31823a5217. Am J Clin Oncol. 2013. PMID: 22237146

9

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.

Gil EY, Jo UH, Jeong H, Whang YM, Woo OH, Cho KR, Seo JH, Kim A, Lee ES, Koh I, Kim YH, Park KH. Gil EY, et al. Int J Oncol. 2012 Aug;41(2):611-20. doi: 10.3892/ijo.2012.1470. Epub 2012 May 10. Int J Oncol. 2012. PMID: 22581300

10

Association between -276 C/T polymorphism of the ERBB3 gene and lung cancer risk in a Korean population.

Sung JS, Jin L, Jo U, Park KH, Kim YH. Sung JS, et al. Among authors: jo u. Anticancer Res. 2012 Oct;32(10):4433-7. Anticancer Res. 2012. PMID: 23060569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters